Is pharmaceutical policy evidence-informed? A case of the deregulation process of nicotine replacement therapy products in Finland

Health Policy

Volumn 105, Issue 2-3, 2012, Pages 246-255

  Kurko, Terhi ^a   Silvast, Antti ^a   Wahlroos, Hannes ^b   Pietilä, Kirsi ^c   Airaksinen, Marja ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Espoo 7th (Tapiolan Otso) Pharmacy   (Finland)

^c Pharmacy of Malmi   (Finland)

Author keywords

Deregulation; Evidence informed decision making; Nicotine replacement therapy; Pharmaceutical policy; Qualitative research

Indexed keywords

NICOTINE;

ARTICLE; CONTENT ANALYSIS; DEREGULATION; FINLAND; GOVERNMENT REGULATION; HEALTH CARE POLICY; HUMAN; MEDICOLEGAL ASPECT; NICOTINE REPLACEMENT THERAPY; PUBLIC HEALTH; SMOKING CESSATION;

DECISION MAKING, ORGANIZATIONAL; EVIDENCE-BASED MEDICINE; FINLAND; GOVERNMENT REGULATION; HEALTH POLICY; HUMANS; POLITICS; TOBACCO USE CESSATION PRODUCTS;

EID: 84859781493     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2012.02.013     Document Type: Article

References (40)

1. Cochrane A.L. Effectiveness and efficiency: random reflections on health services 1972, Nuffield Provincial Hospitals Trust, London.
2. Taubes G. Looking for the evidence in medicine. Science 1996, 272:22-24.
3. WHO Effective medicines regulation: ensuring safety, efficacy and quality 2003, WHO Policy Perspectives on Medicines. http://apps.who.int/medicinedocs/pdf/s4921e/s4921e.pdf.
4. Maynard A., Bloor K. Dilemmas in regulation of the market of pharmaceuticals. Health Affairs 2003, 22(3):31-41.
5. Mossialos E., Walley T., Mrazek M. Regulating pharmaceuticals in Europe: an overview 2004, Berkshire Open University Press. http://books.google.com/books%3Fid=vmstEnVcMZsC%26printsec=frontcover%26hl=fi%26source=gbs_ge_summary_r%26cad=0%23v=onepage%26q%26f=false.
6. Fox D.M. Evidence of evidence-based health policy: the politics of systematic reviews in coverage decisions. Health Affairs 2005, 24(1):1114-1122.
7. Helmiö T., Karjalainen A., Närhi U. Pharmaceuticals in the goal of Health Policy. TABU. Medicines Information from National Agency of Medicines 2005, 13(5):11-17. [in Finnish].
8. Green C.J., Maclure M., Fortin P.M., Ramsay C.R., Aaserud M., Bardal S. Pharmaceutical policies: effects of restrictions on reimbursement. Cochrane Database of Systematic Reviews 2010, 8:CD008654.
9. Almarsdóttir A.B., Traulsen J.M. Multimethod research into policy changes in the pharmacy sector-the Nordic case. Research in Social Administrative Pharmacy 2009, 5(1):82-90.
10. European Public Health Alliance, 2009. EPHA welcomes transfer of pharmaceutical policy to DG Sanco. EPHA press release 2004. http://www.epha.org/a/3765.
11. Noerreslet M., Larsen J.B., Traulsen J.M. The medicine-user-lost in translation? Analysis of the official political debate prior to the deregulation of the Danish medicine distribution system. Social Science and Medicine 2005, 61(8):1733-1740.
12. Shiffman S., Sweeney C.T. Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability?. Health Policy 2008, 86(1):17-26.
13. Kurko T., Linden K., Vasama M., Pietilä K., Airaksinen M. Nicotine replacement therapy practices in Finland one year after deregulation of the product sales-has anything changed from the community pharmacy perspective?. Health Policy 2009, 91:277-285.
14. Dobrow M.J., Goel V., Upshur R.E.G. Evidence-based health policy: context and utilization. Social Science and Medicine 2004, 58(1):207-217.
15. Oxman A.D., Lavis J.N., Lewin S., Fretheim A. SUPPORT tools for evidence-informed health Policymaking (STP) I: what is evidence-informed policymaking?. Health Research Policy and Systems 2009, 7(SI).
16. Lyles A. Evidence- or opinion-based pharmaceutical policy?. Clinical Therapeutics 2004, 26(11):1922-1923.
17. Aaserud M., Austvoll-Dahlgren A., Sturm H., Kösters J.P., Hill S., Furberg C., et al. Pharmaceutical policies: effects on rational drug use, an overview of 13 reviews. Cochrane Database of Systematic Reviews 2006, 2:CD004397.
18. Tobacco Act (693/1976) 1976. http://www.finlex.fi/en/laki/kaannokset/1976/en19760693.pdf.
19. Statistics Finland Tobacco statistics 2009 2009, Official statistics of Finland, Helsinki. http://www.stat.fi/til/tup/2009/tup_2009_2010-12-22_fi.pdf.
20. WHO Parties to the WHO framework convention on tobacco control 2011, http://www.who.int/fctc/signatories_parties/en/index.html.
21. Working group set up by the Finnish Medical Society Duodecim & the Finnish Association for General Practice Smoking, nicotine dependency and nicotine withdrawal. Current Care Summary; 2007, http://www.kaypahoito.fi/web/english/summaries/naytaartikkeli/tunnus/ccs00026.
22. Kurko T., Linden K., Pietilä K., Sandström P., Airaksinen M. Community pharmacists' involvement in smoking cessation: familiarity and implementation of the National smoking cessation guideline in Finland. BMC Public Health 2009, 10:444.
23. Helakorpi S., Pajunen T., Jallinoja P., Virtanen S., Uutela A. Health behavior and health among the Finnish adult population, Spring 2010 2011, National Institute for Health and Welfare, p. 15 [in Finnish].
24. Medicines Act and Decree and Amendments (395/1987); 1987, http://www.fimea.fi/instancedata/prime_product_julkaisu/fimea/embeds/fimeawwwstructure/18580_Laakelaki_englanniksi_paivitetty_5_2011.pdf.
25. Mossialos E., Srivastava D. Overview of the pharmaceutical system in Finland. Pharmaceutical policies in Finland. Challenges and opportunities. Observatory studies series 2008, vol. 10:5-49. European Observatory on Health Systems and Policies and Ministry of Social Affairs and Health, [Chapter 2].
26. Ministry of Social Affairs and Health Pharmaceutical policy 2010 2003, Ministry of Social Affairs and Health, Helsinki, p. 11 [in Finnish].
27. Lindberg M. Nicotine preparations may turn to be reimbursed cessation medicines. Helsingin Sanomat 2004, August, Sect. A6 [in Finnish].
28. Finnish parliament: Handling of parliamentary business; 2012, http://web.eduskunta.fi/dman/Document.phx%3FdocumentId=lv33107143656118.
29. Memorandum of the Working Group on monitoring the sales of nicotine preparations 2007, Ministry of Social Affairs and Health, Helsinki, p. 21 [in Finnish].
30. Minister of Social Affairs and Health Nicotine products will be released to restaurant sale 2009, Notice of Ministry of Social Affairs and Health, http://www.stm.fi/tiedotteet/tiedote/view/1400425#fi [in Finnish].
31. Elo S., Kyngäs H. The qualitative content analysis process. Journal of Advanced Nursing 2008, 62(1):107-115.
32. Ball W.A. A pragmatic framework for the evaluation of policy arguments. Policy Studies Review 1995, 14(1-2):3-24.
33. Jansen M.W.J., Oers H.A.M., Kok G., de Vries N.K. Public health: disconnections between policy, practice and research. Health Research Policy and Systems 2010, 8:37.
34. Nutley S., Morton S., Jung T., Boaz A. Evidence and policy in six European countries: diverse approaches and common challenges. Evidence and Policy 2010, 6(2):131-144.
35. Brownson R.C., Fielding J.E., Maylahn C.M. Evidence-based public health: a fundamental concept for public health practice. Annual Review of Public Health 2009, 30:175-201.
36. Simonen O., Viitanen E., Konu A., Blom M. Effectiveness in political-administrative decision-making in specialized health care. Scandinavian Journal of Public Health 2009, 37(5):494-502.
37. Lyles A. Analytic reasoning for evidence-based public administration: adapting education to practice realities. Evidence-based public management: practices, issues and prospects 2011, M.E. Sharpe Publishes, Armok, NY. A. Shillabeer, T.F. Buss, D.M. Rousseau (Eds.).
38. Patten S., Grigoriadis S., Beaulieu S. Clinical effectiveness, construct and assessment. Journal of Affective Disorders 2011, 132(S1):S3-S8.
39. McCaughey D., Bruning N.S. Rationality versus reality: the challenges of evidence-based decision making for health policy makers. Implementation Science 2010, 5:39.
40. Apollonio D.E., Bero L.A. Evidence and argumentation in policymaking: development of workplace smoking restrictions. BMC Public Health 2009, 9:189.